Project Grant HT9425261E338
- Federal Project Grant Award Summary The Johns Hopkins University received a $120,437 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026 through August 31, 2029. The project, titled "Chemotherapy Induction Regimen for Lineage Switch AML," supports investigator-initiated biomedical research addressing Service Member health and battlefield medicine priorities. The award will be...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a Project Grant totaling $776,831 under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award supports research on P2 purinergic receptors in pancreatic ductal adenocarcinoma as therapeutic targets, conducted at the institution's Baltimore, Maryland facility. This three-year research initiative represents DHA's investment...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a $1.553 million Project Grant effective October 1, 2025, through September 30, 2028, under the Military Medical Research and Development program (CFDA 12.420). This award funds research investigating the impact of breast tissue microbiota on breast cancer progression. The research will be conducted at Johns Hopkins' Baltimore, Maryland facility and aligns with the DHA's mission to support biomedical...
- The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
- Federal Grant Award Summary The Johns Hopkins University received a $823,267 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award funds research investigating mitochondrial heteroplasmy as a novel risk factor for myelodysplastic syndromes, a three-year biomedical research initiative conducted at the institution's Baltimore, Maryland facility. This research...
- Federal Grant Award Summary The Johns Hopkins University received a $232,878 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2025 through May 31, 2027. The award supports research exploring the role of epitranscriptomics in the evolution of neuroendocrine prostate cancer, conducted at the institution's Baltimore, Maryland facility. This research initiative contributes to the DHA's broader mission of...
- The Johns Hopkins University was awarded a $320,165 project grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025 through September 30, 2027. The award supports research investigating the relationship between social determinants of health, biological aging, and disease progression in multiple sclerosis (MS). This research is conducted at the institution's Baltimore, Maryland location and aligns with the Defense...
- Federal Grant Award Summary The Johns Hopkins University received a $610,059 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2028. The award supports research investigating "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis," which addresses critical gaps in understanding how age-related changes in the tumor microenvironment contribute to pancreatic...
- Federal Grant Award Summary The Johns Hopkins University received a $318,483 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award funds research titled "Quantitative Measurement of Acute and Chronic Lesion Activity in a Real-World Multisite Clinical MRI Dataset," which aims to develop quantitative methodologies for analyzing magnetic resonance imaging (MRI)...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a $1.39 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026 through August 31, 2029. The project, titled "Leveraging Germline and Somatic ATM Status in Patients with Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma," supports basic and applied biomedical research investigating the role of...
The Defense Health Agency awarded The Johns Hopkins University a $560,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on September 15, 2026, with a completion date of September 14, 2028. The award supports research targeting the nascent polypeptide-associated complex (NAC) to block oncogenic myristoylation in diffuse large B-cell lymphoma. This research initiative aims to investigate novel therapeutic mechanisms for preventing aberrant protein modifications that drive lymphoma oncogenesis, contributing to the Defense Health Agency's broader portfolio of biomedical research addressing Service Member health and military-relevant medical conditions. The two-year project will be conducted at The Johns Hopkins University's Baltimore, Maryland facility, leveraging the institution's extensive experience as a premier research partner with the federal government. Johns Hopkins will deliver investigator-initiated research outcomes designed to advance understanding of lymphoma biology and develop potential therapeutic interventions. As a major recipient of Defense Health Agency funding, Johns Hopkins brings significant expertise in translational biomedical research and has a demonstrated track record of successfully completing federally-funded investigations across oncology and related disease areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $560.0k | 7/6/26 |